Cover Image

Discovery of novel STAT3 inhibitors with anti-breast cancer activity: structure-based virtual screening, molecular dynamics and biological evaluation.

Fuente: PubMed

Saved in:

Bibliographic Details
Main Authors:	Wang, Jinhui, Zhang, Peijie, Yu, Yalin, Yi, Yan, Jiang, Yongjun, Hu, Shiwei
Format:	Artículo científico
Language:	en
Published:	RSC medicinal chemistry 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation
by: Wenxiu Sun, et al.
Published: (2024)

Discovery of novel MurB inhibitors through common feature pharmacophore–based virtual screening and in vitro biological evaluation
by: Aoqi Luo, et al.
Published: (2025)

Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation
by: Roufen Chen, et al.
Published: (2024)

Discovering novel derivatives of STAT3 and HDAC inhibitors with anti‐tumor activity
by: Yu Yang, et al.
Published: (2024)

Design, synthesis, and biological evaluation of naphthoylamide derivatives as inhibitors of STAT3 phosphorylation
by: JiaHao Lu, et al.
Published: (2024)

Discovery of novel uridine‐based chitin synthase inhibitors: Design, synthesis and structure–activity relationships
by: Xiangyang Lv, et al.
Published: (2026)

Discovery of the tryptanthrin‐derived indoloquinazoline as an anti‐breast cancer agent via ERK/JNK activation
by: Chih‐Shiang Chang, et al.
Published: (2024)

A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
by: Marvin Xuejun Xu, et al.
Published: (2025)

Structure‐based virtual screening of novel chitin synthase inhibitors for the control of Phytophthora sojae
by: Yuansheng Liu, et al.
Published: (2024)

STAT3 phosphorylation inhibitor Bt354 exhibits anti‐neoplastic activity in glioblastoma multiforme cells
by: Yi‐Chun Chiang, et al.
Published: (2024)

Discovery of novel, high‐affinity HBV T‐cell epitopes by molecular dynamics‐augmented proteome‐wide screening
by: Mingchen Yan, et al.
Published: (2026)

Risk‐based breast cancer screening noninferior to annual screening
by: Leah Lawrence
Published: (2026)

Exploring the co‐activity of FDA approved drug gemcitabine and docetaxel for enhanced anti‐breast cancer activity: DFT, docking, molecular dynamics simulation and pharmacophore studies
by: Sureba Sukumaran, et al.
Published: (2024)

Toward novel anti‐inflammatory PI3Kδ inhibitors: A virtual screening approach leveraging consensus pharmacophore models and multi‐algorithm docking
by: Yajing Sheng, et al.
Published: (2026)

iNOS/PGE2 inhibitors as a novel template for analgesic/anti‐inflammatory activity: Design, synthesis, in vitro biological activity and docking studies
by: Ayca Erdogan, et al.
Published: (2024)

Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy‐based virtual screening and machine learning evaluation
by: Xi Chen, et al.
Published: (2024)

Exploration of novel plumbagin derivatives as anti‐liver cancer inhibitors of VEGFR‐2: Designing, ADMET, QSAR models, and molecular docking
by: Nguyen Minh Quang, et al.
Published: (2025)

Discovery of therapeutic promising natural products to target Kv1.3 channel, a transmembrane protein regulating immune disorders, through multidimensional virtual screening, molecular dynamics simulations and biological validation.
by: Zhang, Shanshan, et al.
Published: (2025)

Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
by: Rachana Upadhyay, et al.
Published: (2024)

Discovery of new PSII inhibitors: systematic investigation for herbicidal activity screening, properties, and mode of action
by: Mirjalol Umurzokov, et al.
Published: (2025)

Transmembrane protein 25 abrogates monomeric EGFR‐driven STAT3 activation in triple‐negative breast cancer
by: Chakrabhavi Dhananjaya Mohan, et al.
Published: (2024)

Total triterpenoids from apple peels exert pronounced anti‐breast‐cancer activity in vivo and in vitro
by: Wanyu Yan, et al.
Published: (2024)

Identification of novel amides and alkaloids as putative inhibitors of dopamine transporter for schizophrenia using computer-aided virtual screening.
by: Ahmad, Iqra, et al.
Published: (2025)

Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
by: Rui Zhang, et al.
Published: (2024)

Discovery of novel chromone and acrylate‐based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity
by: Prashant S. Auti, et al.
Published: (2024)

Flagellate bacteria‐mediated tumour antigen delivery: A novel approach to enhance dendritic cell activation for in situ cancer vaccination
by: Wen Xia, et al.
Published: (2024)

Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway
by: Yalin Zhu, et al.
Published: (2024)

Hit to lead optimization of carbothioate derivatives as novel succinate dehydrogenase inhibitors using a multistep virtual screening approach
by: Cong Zhou, et al.
Published: (2025)

Isobavachalcone, a natural sirtuin 2 inhibitor, exhibits anti‐triple‐negative breast cancer efficacy in vitro and in vivo
by: Ya‐li Ren, et al.
Published: (2024)

PDP1 promotes the progression of breast cancer through STAT3 pathway
by: Yufeng Wang, et al.
Published: (2024)

Suppression of CDC42 potential in breast cancer tumor microenvironment by tumor necrosis factor inhibitors
by: Yi‐Yu Chou, et al.
Published: (2024)

Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
by: Yuechen Wang, et al.
Published: (2024)

Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups
by: Bo Han, et al.
Published: (2024)

Synthesis, antifungal activity, and molecular simulation study of nootkatone‐based thiazole‐hydrazone compounds as novel succinate dehydrogenase inhibitor
by: Maofang Yang, et al.
Published: (2025)

Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine‐containing hydrazone derivatives as cholinesterase inhibitors
by: Fatih Tok, et al.
Published: (2024)

Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
by: Anastasia D. Fomina, et al.
Published: (2024)

Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.
by: Wang, Lijun, et al.
Published: (2026)

Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
by: Yasmin M. Syam, et al.
Published: (2024)

Potential biological roles of exosomal non‐coding RNAs in breast cancer
by: Xiang Li, et al.
Published: (2025)

Evaluation of genes and molecular pathways involved in ferroptosis in breast cancer: A systems biology and bioinformatics approach.
by: Heydari, Arezu, et al.
Published: (2025)